{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:20:08Z","timestamp":1791624008196,"version":"4.3.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Anti-M\u00fcllerian Hormone (AMH) is a 140 kDa homodimeric glycoprotein consisting of two identical subunits linked by disulphide bonds and is synthesised by the testes and ovaries. Its clinical applications are prediction of ovarian response and gonadotropin dose selection upon\n                    <jats:italic>in vitro<\/jats:italic>\n                    fertilization. In males, AMH is used to investigate sexual developmental disorders and gonadal function. AMH is commonly assayed by enzyme-linked immunosorbent assay or automated immunoassay formats that show variation between methods. This review applies fundamental chemical pathology concepts to explain the observed analytical variation of AMH measurement. We examine the lack of standardisation between AMH assays, the impact of antibody design on variable measurements, consider the analytical detection of AMH isoforms, review analytical interference in AMH measurement, and briefly assess systematic bias between AMH assays. The improved attempt at standardising AMH measurement by the recent approval of a WHO Reference Reagent offers promise for harmonising immunoassay results and establishing consensus medical cut-off points for AMH in disease. Standardisation, however, will need to redress the issue of poor commutability of standard reference material and further assign a standard reference procedure to quantify AMH standard reference material. The improvement of the analytical phase of AMH testing will support harmonised method development and patient care.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2021.719029","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T06:46:10Z","timestamp":1630737970000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Variation in the Measurement of Anti-M\u00fcllerian Hormone \u2013 What Are the Laboratory Issues?"],"prefix":"10.3389","volume":"12","author":[{"given":"Rivak","family":"Punchoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Bhoora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the Bovine and Human Genes for M\u00fcllerian Inhibiting Substance and Expression of the Human Gene in Animal Cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gat024","article-title":"Which Follicles Make the Most Anti-Mullerian Hormone in Humans? Evidence for an Abrupt Decline in AMH Production at the Time of Follicle Selection","volume":"19","author":"Jeppesen","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2010.02.016","article-title":"Anti-M\u00fcllerian Hormone (AMH): Regulator and Marker of Ovarian Function","volume":"71","author":"van Houten","year":"2010","journal-title":"Ann Endocrinol (Paris)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian Reserve Testing: A User's Guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"128907","DOI":"10.1155\/2013\/128907","article-title":"Serum AMH in Physiology and Pathology of Male Gonads","volume":"2013","author":"Matuszczak","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000087","article-title":"Maximizing the Clinical Utility of Antim\u00fcllerian Hormone Testing in Women's Health","volume":"26","author":"Leader","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt062","article-title":"The Physiology and Clinical Utility of Anti-Mullerian Hormone in Women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B9","volume-title":"AMH Gen II ELISA","year":"2009"},{"key":"B10","volume-title":"Ultra-Sensitive AMH\/MIS Webster","year":"2014"},{"key":"B11","volume-title":"Access Anti-M\u00fcllerian Hormone (AMH)","year":"2017"},{"key":"B12","volume-title":"Meno-Check\u00ae picoAMH ELISA Webster","year":"2018"},{"key":"B13","volume-title":"Elecsys\u00ae AMH (Anti-Mullerian Hormone)","year":"2021"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0022-1759(92)90061-W","article-title":"Enzyme Immunoassay Techniques. An Overview","volume":"150","author":"Porstmann","year":"1992","journal-title":"J Immunol Methods"},{"key":"B15","article-title":"Quality Control of the Analytical Examination Process","volume-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","author":"Miller","year":"2018"},{"key":"B16","volume-title":"The Complete ELISA Guide","year":"2021"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2018.08.012","article-title":"Towards International Standardization of Immunoassays for M\u00fcllerian Inhibiting Substance\/Anti-M\u00fcllerian Hormone","volume":"37","author":"Ferguson","year":"2018","journal-title":"Reprod BioMed Online"},{"key":"B18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12958-020-00641-9","article-title":"Establishment of a WHO Reference Reagent for Anti-Mullerian Hormone","volume":"18","author":"Ferguson","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"B19","first-page":"15194","volume-title":"In Vitro Diagnostic Medical Devices \u2014 Measurement of Quantities in Samples of Biological Origin \u2014 Description of Reference Materials","year":"2002"},{"key":"B20","volume-title":"In Vitro Diagnostic Medical Devices \u2014 Measurement of Quantities in Biological Samples \u2014 Metrological Traceability of Values Assigned to Calibrators and Control Materials. ISO 17511","year":"2003"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2011.06.011","article-title":"The Journey From the Old to the New AMH Assay: How to Avoid Getting Lost in the Values","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod BioMed Online"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-14-2-152","article-title":"Mullerian Inhibiting Substance: A Gonadal Hormone With Multiple Functions","volume":"14","author":"Lee","year":"1993","journal-title":"Endocr Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.1080320213","article-title":"M\u00fcllerian Inhibiting Substance in Reproduction and Cancer","volume":"32","author":"Donahoe","year":"1992","journal-title":"Mol Reprod Dev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.15.7711","article-title":"Bioactivation of M\u00fcllerian Inhibiting Substance During Gonadal Development by a Kex2\/Subtilisin-Like Endoprotease","volume":"93","author":"Nachtigal","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)37375-7","article-title":"Proteolytic Processing of Mullerian Inhibiting Substance Produces a Transforming Growth Factor-Beta-Like Fragment","volume":"263","author":"Pepinsky","year":"1988","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0273","article-title":"Processing of Anti-Mullerian Hormone Regulates Receptor Activation by a Mechanism Distinct From TGF-Beta","volume":"24","author":"di Clemente","year":"2010","journal-title":"Mol Endocrinol (Baltimore Md)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00395.2013","article-title":"Human Blood Contains Both the Uncleaved Precursor of Anti-Mullerian Hormone and a Complex of the NH2- and COOH-Terminal Peptides","volume":"305","author":"Pankhurst","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.fertnstert.2019.03.002","article-title":"Associations of Different Molecular Forms of Antim\u00fcllerian Hormone and Biomarkers of Polycystic Ovary Syndrome and Normal Women","volume":"112","author":"Wissing","year":"2019","journal-title":"Fertil Steril"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.04.042","article-title":"Ovarian Antim\u00fcLlerian Hormone System: More Complex Than was Thought","volume":"112","author":"La Marca","year":"2019","journal-title":"Fertil Steril"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-1-11","article-title":"Serum Levels of M\u00fcllerian Inhibiting Substance in Boys From Birth to 18 Years, as Determined by Enzyme Immunoassay","volume":"70","author":"Baker","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jcem-70-1-16","article-title":"An Immunoassay to Detect Human M\u00fcllerian Inhibiting Substance in Males and Females During Normal Development","volume":"70","author":"Hudson","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.2.6378","article-title":"Detection of Minimal Levels of Serum Anti-M\u00fcllerian Hormone During Follow-Up of Patients With Ovarian Granulosa Cell Tumor by Means of a Highly Sensitive Enzyme-Linked Immunosorbent Assay","volume":"85","author":"Long","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/BF00220465","article-title":"Variants of the Anti-M\u00fcllerian Hormone Gene in a Compound Heterozygote With the Persistent M\u00fcllerian Duct Syndrome and His Family","volume":"90","author":"Carr\u00e9-Eus\u00e8be","year":"1992","journal-title":"Hum Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.02.046","article-title":"Comparability of Antim\u00fcllerian Hormone Levels Among Commercially Available Immunoassays","volume":"101","author":"Su","year":"2014","journal-title":"Fertil Steril"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0022-1759(92)90083-6","article-title":"Increased ELISA Sensitivity Using a Modified Method for Conjugating Horseradish Peroxidase to Monoclonal Antibodies","volume":"152","author":"Madersbacher","year":"1992","journal-title":"J Immunol Methods"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/45.7.942","article-title":"Human Anti-Animal Antibody Interferences in Immunological Assays","volume":"45","author":"Kricka","year":"1999","journal-title":"Clin Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/46.8.1037","article-title":"Interferences in Immunoassay\u2013Still a Threat","volume":"46","author":"Kricka","year":"2000","journal-title":"Clin Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/000456329903600603","article-title":"Interference in Immunoassay","volume":"36","author":"Selby","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"B39","volume-title":"Why Should Patients be Worried About Biotin","year":"2021"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1373\/jalm.2017.024257","article-title":"Biotin Interference in Clinical Immunoassays","volume":"2","author":"Colon","year":"2018","journal-title":"J Appl Lab Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4158\/EP12158.OR","article-title":"Falsely Low Parathyroid Hormone Secondary to Biotin Interference: A Case Series","volume":"19","author":"Waghray","year":"2013","journal-title":"Endocr Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1515\/cclm-2019-0496","article-title":"Assessment of Complement Interference in Anti-M\u00fcllerian Hormone Immunoassays","volume":"58","author":"Turner","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu050","article-title":"Pre-Mixing Serum Samples With Assay Buffer Is a Prerequisite for Reproducible Anti-Mullerian Hormone Measurement Using the Beckman Coulter Gen II Assay","volume":"29","author":"Han","year":"2014","journal-title":"Hum Reprod"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2013.04.005","article-title":"Within-Laboratory and Between-Laboratory Variability in the Measurement of Anti-M\u00fcllerian Hormone Determined Within an External Quality Assurance Scheme","volume":"13","author":"Zuvela","year":"2013","journal-title":"Reprod Biol"},{"key":"B45","unstructured":"Fertility Problems: Assessment and Treatment: National Institute for Health and Care Excellence (NICE)2013"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2188","article-title":"Limited Value of Ovarian Function Markers Following Orthotopic Transplantation of Ovarian Tissue After Gonadotoxic Treatment","volume":"96","author":"Janse","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2020.08.011","article-title":"Diagnostic Value of Anti-Mullerian Hormone in Ovarian Granulosa Cell Tumor: A Meta-Analysis","volume":"253","author":"Chen","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e318270ac69","article-title":"Anti-M\u00fcllerian Hormone Level in Older Women: Detection of Granulosa Cell Tumor Recurrence","volume":"22","author":"Chong","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70333-2","article-title":"Antim\u00fcllerian Hormone as a Serum Marker of Granulosa Cell Tumorsof the Ovary: Comparative Study With Serum Alpha-Inhibin and Estradiol","volume":"174","author":"Rey","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"B50","volume-title":"Clinical Chemistry: Theory, Analysis, Correlation","author":"Kaplan","year":"2003"},{"key":"B51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12958-015-0101-5","article-title":"Comparison of Two Different Methods for Measuring Anti-Mullerian Hormone in a Clinical Series","volume":"13","author":"Hyldgaard","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"B52","article-title":"First Fully Automated Immunoassay for Anti-M\u00fcllerian Hormone (AMH) on the Cobas E Analyzers","author":"Klemt","year":"2014"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two New Automated, Compared With Two Enzyme-Linked Immunosorbent, Antim\u00fcllerian Hormone Assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev127","article-title":"Performance of the Two New Fully Automated Anti-M\u00fcllerian Hormone Immunoassays Compared With the Clinical Standard Assay","volume":"30","author":"van Helden","year":"2015","journal-title":"Hum Reprod"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12958-016-0143-3","article-title":"Assessment of the Access AMH Assay as an Automated, High-Performance Replacement for the AMH Generation II Manual ELISA","volume":"14","author":"Pearson","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu036","article-title":"A Single-Centre Evaluation of Two New Anti-Mullerian Hormone Assays and Comparison With the Current Clinical Standard Assay","volume":"29","author":"Welsh","year":"2014","journal-title":"Hum Reprod"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-012-9880-1","article-title":"Correlation Between Three Assay Systems for Anti-M\u00fcllerian Hormone (AMH) Determination","volume":"29","author":"Li","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.08.045","article-title":"New Automated Antim\u00fcLlerian Hormone Assays Are More Reliable Than the Manual Assay in Patients With Reduced Antral Follicle Count","volume":"106","author":"Tadros","year":"2016","journal-title":"Fertil Steril"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.fertnstert.2015.12.023","article-title":"Comparative Assessment of Five Serum Antim\u00fcllerian Hormone Assays for the Diagnosis of Polycystic Ovary Syndrome","volume":"105","author":"Pigny","year":"2016","journal-title":"Fertil Steril"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew248","article-title":"Comparative Evaluation of Three New Commercial Immunoassays for Anti-M\u00fcllerian Hormone Measurement","volume":"31","author":"Li","year":"2016","journal-title":"Hum Reprod"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex219","article-title":"Non-Equivalence of Anti-M\u00fcllerian Hormone Automated Assays-Clinical Implications for Use as a Companion Diagnostic for Individualised Gonadotrophin Dosing","volume":"32","author":"Iliodromiti","year":"2017","journal-title":"Hum Reprod"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2014-0022","article-title":"First Fully Automated Immunoassay for Anti-M\u00fcllerian Hormone","volume":"52","author":"Gassner","year":"2014","journal-title":"Clin Chem Lab Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.719029\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T06:46:20Z","timestamp":1630737980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.719029\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":62,"alternative-id":["10.3389\/fendo.2021.719029"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.719029","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"article-number":"719029"}}